These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 19175039)
41. Loss of hMSH2 and hMSH6 expression is frequent in sporadic endometrial carcinomas with microsatellite instability: a population-based study. Stefansson I; Akslen LA; MacDonald N; Ryan A; Das S; Jacobs IJ; Salvesen HB Clin Cancer Res; 2002 Jan; 8(1):138-43. PubMed ID: 11801550 [TBL] [Abstract][Full Text] [Related]
42. Genetic polymorphisms in Si W; Kang S; Sun H; Chen J; Cao S; Li Y Int J Gynecol Cancer; 2019 Sep; 29(7):1148-1155. PubMed ID: 31273068 [TBL] [Abstract][Full Text] [Related]
43. Hypermethylation of mismatch repair gene hMSH2 associates with platinum-resistant disease in epithelial ovarian cancer. Tian H; Yan L; Xiao-Fei L; Hai-Yan S; Juan C; Shan K Clin Epigenetics; 2019 Oct; 11(1):153. PubMed ID: 31666131 [TBL] [Abstract][Full Text] [Related]
44. Loss of protein expression of hMLH1 and hMSH2 with double primary carcinomas of the stomach and colorectum. Yamamoto M; Taguchi K; Baba H; Endo K; Kohnoe S; Okamura T; Maehara Y Oncol Rep; 2006 Jul; 16(1):41-7. PubMed ID: 16786121 [TBL] [Abstract][Full Text] [Related]
45. Defective mismatch repair and the development of recurrent endometrial carcinoma. Pijnenborg JM; Dam-de Veen GC; de Haan J; van Engeland M; Groothuis PG Gynecol Oncol; 2004 Aug; 94(2):550-9. PubMed ID: 15297202 [TBL] [Abstract][Full Text] [Related]
46. Tobacco and inflammation effects in immunoexpression of hMSH2 and hMLH1 in epithelium of oral mucosa. Fernandes AM; De Souza VR; Springer CR; Cardoso SV; Loyola AM; Mesquita RA; Aguiar MC Anticancer Res; 2007; 27(4B):2433-7. PubMed ID: 17695535 [TBL] [Abstract][Full Text] [Related]
47. Roles of mismatch repair proteins hMSH2 and hMLH1 in the development of sporadic breast cancer. Murata H; Khattar NH; Gu L; Li GM Cancer Lett; 2005 Jun; 223(1):143-50. PubMed ID: 15890247 [TBL] [Abstract][Full Text] [Related]
48. hMLH1 and hMSH2 expression in human hepatocellular carcinoma. Wang L; Bani-Hani A; Montoya DP; Roche PC; Thibodeau SN; Burgart LJ; Roberts LR Int J Oncol; 2001 Sep; 19(3):567-70. PubMed ID: 11494037 [TBL] [Abstract][Full Text] [Related]
49. The significance of mismatch repair genes in gastric cancer. Lee HJ; Jang YJ; Lee EJ; Kim JH; Park SS; Park SH; Kim CS; Mok YJ J Cancer Res Ther; 2013; 9(1):80-3. PubMed ID: 23575079 [TBL] [Abstract][Full Text] [Related]
50. Expression of DNA mismatch repair proteins hMSH2 and hMLH1 and the cyclin G1 inhibitor, p21(waf1/cip1) in pediatric tumors: correlation with response to therapy. Idikio HA Oncol Rep; 2001; 8(5):965-71. PubMed ID: 11496300 [TBL] [Abstract][Full Text] [Related]
51. Expression of factors involved in regulation of DNA mismatch repair- and apoptosis pathways in ovarian cancer patients. Materna V; Surowiak P; Markwitz E; Spaczynski M; Drag-Zalesinska M; Zabel M; Lage H Oncol Rep; 2007 Mar; 17(3):505-16. PubMed ID: 17273726 [TBL] [Abstract][Full Text] [Related]
52. [Mismatch repair gene promoter methylation and expression in hydatidiform moles and the malignant transformation]. Zhu CK; Ye DF; Xie X; Cheng XD; Chen HZ; Lu WG Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Aug; 25(4):422-6. PubMed ID: 12974087 [TBL] [Abstract][Full Text] [Related]
53. Unbalanced germ-line expression of hMLH1 and hMSH2 alleles in hereditary nonpolyposis colorectal cancer. Curia MC; Palmirotta R; Aceto G; Messerini L; Verì MC; Crognale S; Valanzano R; Ficari F; Fracasso P; Stigliano V; Tonelli F; Casale V; Guadagni F; Battista P; Mariani-Costantini R; Cama A Cancer Res; 1999 Aug; 59(15):3570-5. PubMed ID: 10446963 [TBL] [Abstract][Full Text] [Related]
54. Reduced host cell reactivation of oxidative DNA damage in human cells deficient in the mismatch repair gene hMSH2. Pitsikas P; Lee D; Rainbow AJ Mutagenesis; 2007 May; 22(3):235-43. PubMed ID: 17351251 [TBL] [Abstract][Full Text] [Related]
55. Protein expression and methylation of DNA repair genes hMLH1, hMSH2, MGMT and BRCA1 and their correlation with clinicopathological parameters and prognosis in basal-like breast cancer. Alkam Y; Mitomi H; Nakai K; Himuro T; Saito T; Takahashi M; Arakawa A; Yao T; Saito M Histopathology; 2013 Nov; 63(5):713-25. PubMed ID: 24004112 [TBL] [Abstract][Full Text] [Related]
56. hMSH2 and GTBP expression in advanced stage epithelial ovarian cancer. Ercoli A; Ferrandina G; Raspaglio G; Marone M; Maggiano N; Del Mastro P; Benedetti Panici P; Mancuso S; Scambia G Br J Cancer; 1999 Jul; 80(10):1665-71. PubMed ID: 10408416 [TBL] [Abstract][Full Text] [Related]
57. Immunohistochemical analysis of expression and allelotype of mismatch repair genes (hMLH1 and hMSH2) in bladder cancer. Kassem HS; Varley JM; Hamam SM; Margison GP Br J Cancer; 2001 Feb; 84(3):321-8. PubMed ID: 11161395 [TBL] [Abstract][Full Text] [Related]
58. Microsatellite instability and hMLH1 and hMSH2 expression analysis in soft tissue sarcomas. Kawaguchi K; Oda Y; Takahira T; Saito T; Yamamoto H; Kobayashi C; Tamiya S; Oda S; Iwamoto Y; Tsuneyoshi M Oncol Rep; 2005 Feb; 13(2):241-6. PubMed ID: 15643505 [TBL] [Abstract][Full Text] [Related]
59. Reduced expression of hMSH2 protein is correlated to poor survival for soft tissue sarcoma patients. Taubert HW; Bartel F; Kappler M; Schuster K; Meye A; Lautenschläger C; Thamm-Mücke B; Bache M; Schmidt H; Holzhausen HJ; Würl P Cancer; 2003 May; 97(9):2273-8. PubMed ID: 12712483 [TBL] [Abstract][Full Text] [Related]
60. [Effects of 5-Aza-2'-deoxycytidine and trichostatin A on DNA methylation and expression of hMLH1 in ovarian cancer cell line COC1/DDP]. Meng CF; Dai DQ; Guo KJ Ai Zheng; 2008 Dec; 27(12):1251-5. PubMed ID: 19079988 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]